Allergan, Inc. (NYSE:AGN)

20 More Biopharma Catalysts Coming in 2018

Over the course of 2017, biopharmaceutical companies more or less kept pace with the markets, ending up with a return just a little higher than the S&P 500. But going in ...
Read Full Story »

Happy New Year From Allergan: You’re Fired

Drug giant Allergan PLC (NYSE: AGN) announced its intention Wednesday to fire more than 1,000 employees and eliminate another 400 job openings as it continues to cut costs ahead of ...
Read Full Story »

FDA Accepts Allergan and Paratek’s Newest Acne Treatment for Review

Shares of Paratek Pharmaceuticals Inc. (NASDAQ: PRTK) saw a handy gain on Thursday after the firm announced in conjunction with Allergan PLC (NYSE: AGN) that the U.S. Food and Drug ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amazon, Allergan, Borg Warner, Lam Research, Mellanox Technologies, Shake Shack and More

The futures are down this morning as the markets continue to swirl in anticipation of a tax reform package. While the House and the Senate are continuing to work on ...
Read Full Story »

Allergan, Eldorado Gold Slip into Tuesday’s 52-Week Low Club

December 5, 2017: Here are four stocks trading with heavy volume among 83 equities making new 52-week lows in Tuesday's session. On the NYSE decliners led advancers by nearly 2 ...
Read Full Story »

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

With the market looking ready to continue running to all-time highs despite yesterday's selling, many pundits feel this late stage part of the rally is more people trying to get ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Allergan, Autodesk, Home Depot, Marvell, Qualcomm, UnitedHealth, Walmart and More

Stocks screamed higher to all-time records on Tuesday, and the indexes were indicated higher on Wednesday as well. With the markets remaining right at all-time highs, it is important to ...
Read Full Story »

5 Stocks Wall Street ‘Super Investors’ Are Buying This Quarter

Like any business, the world of investing has its share of rock stars: Renowned investors who have struck gold over the years for their clients and piled up sensational long-term ...
Read Full Story »

Allergan, Newell Brands Topple into Thursday’s 52-Week Low Club

October 19, 2017: Here are four stocks trading with heavy volume among 13 equities making new 52-week lows in Thursday's session. On the NYSE, decliners led advancers by about 8 ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Adobe, Allergan, Amex, Baker Hughes, Nike, Northern Dynasty, Sprint, Wayfair and More

Stocks have hit new highs and the Dow Jones Industrial Average blew through 23,000 this week as easily as a knife cutting through butter. Thursday morning was indicated to be ...
Read Full Story »

Wednesday’s Biggest Winners and Losers in the S&P 500

October 18, 2017: The S&P 500 closed relatively flat at 2,561.24. The DJIA closed up 0.69% at 23,156.84. Separately, the Nasdaq was relatively flat at 6,624.22. Wednesday was a positive day for ...
Read Full Story »

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

U.S. pharmaceutical and biotech stocks may have considerable upside if Credit Suisse's views come to pass. The firm is looking at pharma and biotech opportunities around politics, drug pipelines and ...
Read Full Story »

4 UBS Top Pick Growth Stocks to Buy for the Rest of 2017

With the fourth quarter starting next week, and the final three months of 2017 upon us, many of the top firms that we cover on Wall Street are making some ...
Read Full Story »

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech company, it would be in a successful treatment of Alzheimer's ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Altria, Apple, Discovery, DowDuPont, JPMorgan, Red Hat, T-Mobile and More

Stocks were indicated marginally higher on Tuesday morning. Despite three days of selling, the markets did just hit all-time highs again last week. The primary trend that has dominated this eight-year bull ...
Read Full Story »